Abstract: Novel N2-phenylpyrimidine-2,4-diamine compounds, method for preparing the same, and pharmaceutical composition or health functional food are disclosed. The novel N2-phenylpyrimidine-2,4-diamine compounds show potent inhibitory efficacies on EGFR mutations and thus, can be effectively used for the treatment of cancer with EGFR mutations.

Abstract: Novel N2-phenylpyrimidine-2,4-diamine compounds, method for preparing the same, and pharmaceutical composition or health functional food are disclosed. The novel N2-phenylpyrimidine-2,4-diamine compounds show potent inhibitory efficacies on EGFR mutations and thus, can be effectively used for the treatment of cancer with EGFR mutations.

Abstract: Provided is a solar cell module comprising a back sheet including a reflective film including a deposited reflective layer including metal and having 2 or higher optical density (OD), and an UV blocking layer positioned below the reflective film and having 5% or lower transmittance of light at 380 nm wavelength.

Abstract: Provided is a solar cell module comprising a back sheet including a reflective film including a deposited reflective layer including metal and having 2 or higher optical density (OD), and an UV blocking layer positioned below the reflective film and having 5% or lower transmittance of light at 380 nm wavelength.

Abstract: The present invention relates to a solar cell module comprising: a transparent plate; a support plate positioned to face the transparent plate; at least one unit cell disposed between the transparent plate and the support plate; a first filler disposed between the transparent plate and the unit cell; a second filler disposed between the support plate and the unit cell; and a reflective layer which is disposed between the second filler and the support plate, and which reflects sunlight that has passed through the transparent plate on the unit cell, wherein the length of the reflective layer is shorter than the length of the second filler and the second filler directly comes in contact with the support plate. According to this configuration, the amount of sunlight irradiated on the unit cell can be increased, thereby enhancing generating efficiency and improving the durability of the solar cell module.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.

Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.

Abstract: The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.

Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.

Abstract: The invention provides a method and system for communicating, processing and responding to information reporting the status of health care patients. In one aspect, the invention provides a procedure for allocating the attention of health care personnel to issues and events that are reported in association with health care patients located within a health care facility. In some embodiments, assignment of health care personnel to health care patients can be configured according to a set of directives. The directives can direct assignment of personnel based upon many criteria including, but not limited to, the identity and/or location of a health care patient, an issue or event associated with the status of the health care patient, the relative availability of other health care personnel to respond to the issue or event, or a combination thereof.

Abstract: A hydraulic power generating system is disclosed. The hydraulic power generating system includes a looped rail, a plurality of pulleys moving along the looped rail, a plurality of water receiving plates, each being installed to each of the pulleys, side plates which are hingedly coupled to left and right side portions of each of the water receiving plates by hinge shafts, and spread adjusting devices which make the side plates spread against a direction of water flow. Accordingly, since the spread direction of the side plates hingedly coupled to both side portions of the water receiving plate can be changed forward and backward according to the direction of water flow so as to receive a larger amount of water, efficiency in generating power using water energy increases.

Abstract: An inter-stacking module system is provided by mounting an integrated circuit on a first substrate, the first substrate having a first bond pad, mounting an inter-stacking module substrate over the integrated circuit, forming an inter-stacking module bonding pad on the inter-stacking module substrate, and connecting bond wires between the inter-stacking module bonding pad and the first bond pad.

Abstract: The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.